Andy Pasternak

Executive Vice President, Chief Strategy Officer


Andy Pasternak joined Horizon in November 2019. Before joining Horizon, Pasternak led the health care practice in the Americas at Bain & Company Inc., a global management consulting firm. At Bain, he advised boards of directors, CEOs and leadership teams at biopharmaceutical and medical technology companies, as well as private investment funds. His experience spans growth strategy, M&A strategy and execution, organizational design, executive and board governance and performance improvement. Pasternak was also a member of Bain’s Mergers and Acquisition practice, where he served as a leading expert on biopharmaceutical transactions, including acquisitions, business development, licensing deals and divestitures.

Before joining Bain, Pasternak was a founding partner in the Health & Life Sciences practice at Oliver Wyman, a global management consultancy. He also worked in the corporate finance group of J.P. Morgan Securities.

Throughout his career, Pasternak has worked across a wide range of specialty therapeutic areas (including rare diseases) and functions, including commercial, operations and R&D.

Pasternak earned a Master of Business Administration from the University of Chicago and a Bachelor of Arts in economics from Northwestern University.